Regulatory
-
AiMeD hails Union Budget-2024; will give a boost to overall economic growth: Rajiv Nath
14 0The Association of Indian Medical Device Industry (AiMeD) on Tuesday…
Read more -
280 Bio gets US FDA approval to begin phase 1 trial of novel KRAS inhibitor, YL-17231
63 0280Bio, Inc. a clinical stage biotechnology company focused on the…
Read more -
Dr Kannan Vishwanatth, Royal Society of Chemistry fellow develop Breakthrough Innovations in Cancer Treatment.
155 1Rupus Global Founder Dr Kannan Vishwanatth has made Breakthrough in…
Read more -
MTaI urges the Government not to levy TDS on free medical samples to Doctors and Clinicians
113 0Requests reconsideration of TDS provisions on reimbursement of out-of-pocket expenses…
Read more -
Novartis phase IIIb ARGON study meets primary endpoint in a comparison of Enerzair Breezhaler vs free combo of two existing inhaled treatments in uncontrolled asthma
320 0Novartis announced that full results from the phase IIIb ARGON…
Read more -
Swiss healthcare company Roche gets through coronavirus antibody test by Public Health England
177 0The first coronavirus antibody test that could help ease lockdown…
Read more -
MoHFW seeks export ban of anti-TB drugs
159 0Delay in production and receipt of supply may cause an…
Read more -
Anecdotal Evidence of Treating Modern Infectious Diseases Demonstrates Homeopathy can be Effective in Managing Viral Infections such as COVID-19
Anecdotal Evidence of Treating Modern Infectious Diseases Demonstrates Homeopathy can…
Read more -
GSK suspends Ranitidine distribution in India, regulators seek drug testing data from pharma cos
Drugmaker GlaxoSmithKline Pharmaceuticals (GSK) on September 25 said it has…
Read more -
Market Watchdog & Regulator SEBI’s new prescriptions for Transparency & Corporate Governance – Pharma Leaders Report
Market Watchdog & Regulator SEBI’s new prescriptions for Transparency &…
Read more